A detailed history of Federated Hermes, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Federated Hermes, Inc. holds 14,923,545 shares of PFE stock, worth $410 Million. This represents 1.01% of its overall portfolio holdings.

Number of Shares
14,923,545
Previous 14,453,542 3.25%
Holding current value
$410 Million
Previous $401 Million 4.11%
% of portfolio
1.01%
Previous 0.94%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

BUY
$25.26 - $29.6 $11.9 Million - $13.9 Million
470,003 Added 3.25%
14,923,545 $418 Million
Q1 2024

May 14, 2024

BUY
$25.89 - $29.73 $28.6 Million - $32.9 Million
1,105,604 Added 8.28%
14,453,542 $401 Million
Q4 2023

Jan 31, 2024

SELL
$26.13 - $33.94 $20.4 Million - $26.5 Million
-781,269 Reduced 5.53%
13,347,938 $384 Million
Q3 2023

Nov 13, 2023

SELL
$32.09 - $37.51 $47.9 Million - $56 Million
-1,494,153 Reduced 9.56%
14,129,207 $469 Million
Q2 2023

Aug 14, 2023

BUY
$36.12 - $41.79 $86.7 Million - $100 Million
2,399,603 Added 18.15%
15,623,360 $573 Million
Q1 2023

May 08, 2023

BUY
$39.39 - $51.28 $167 Million - $218 Million
4,249,987 Added 47.36%
13,223,757 $540 Million
Q4 2022

Feb 13, 2023

BUY
$41.75 - $54.5 $66.9 Million - $87.3 Million
1,602,318 Added 21.74%
8,973,770 $460 Million
Q3 2022

Nov 14, 2022

BUY
$43.76 - $53.42 $1.08 Million - $1.32 Million
24,752 Added 0.34%
7,371,452 $323 Million
Q2 2022

Aug 15, 2022

BUY
$46.53 - $55.17 $32.7 Million - $38.8 Million
703,529 Added 10.59%
7,346,700 $385 Million
Q1 2022

May 13, 2022

BUY
$45.75 - $56.69 $95.7 Million - $119 Million
2,091,343 Added 45.95%
6,643,171 $344 Million
Q4 2021

Feb 14, 2022

SELL
$41.32 - $61.25 $80.3 Million - $119 Million
-1,942,179 Reduced 29.91%
4,551,828 $269 Million
Q3 2021

Nov 15, 2021

SELL
$39.25 - $50.42 $244 Million - $314 Million
-6,226,238 Reduced 48.95%
6,494,007 $279 Million
Q2 2021

Aug 16, 2021

BUY
$35.91 - $40.68 $29.3 Million - $33.2 Million
815,508 Added 6.85%
12,720,245 $498 Million
Q1 2021

May 13, 2021

SELL
$33.49 - $37.77 $12.4 Million - $13.9 Million
-369,328 Reduced 3.01%
11,904,737 $431 Million
Q4 2020

Feb 12, 2021

SELL
$33.47 - $42.56 $33.6 Million - $42.7 Million
-1,002,629 Reduced 7.55%
12,274,065 $452 Million
Q3 2020

Nov 12, 2020

SELL
$31.75 - $37.25 $5.81 Million - $6.82 Million
-183,114 Reduced 1.36%
13,276,694 $487 Million
Q2 2020

Aug 13, 2020

SELL
$30.12 - $36.54 $101 Million - $123 Million
-3,364,907 Reduced 20.0%
13,459,808 $440 Million
Q1 2020

May 13, 2020

SELL
$27.03 - $38.62 $23 Million - $32.9 Million
-852,674 Reduced 4.82%
16,824,715 $549 Million
Q4 2019

Feb 14, 2020

BUY
$32.92 - $37.36 $202 Million - $229 Million
6,142,206 Added 53.25%
17,677,389 $693 Million
Q3 2019

Nov 14, 2019

BUY
$32.49 - $42.13 $207 Million - $268 Million
6,358,483 Added 122.83%
11,535,183 $414 Million
Q2 2019

Aug 14, 2019

BUY
$36.98 - $41.52 $151 Million - $170 Million
4,088,974 Added 375.92%
5,176,700 $224 Million
Q1 2019

May 10, 2019

BUY
$37.5 - $41.2 $4.21 Million - $4.63 Million
112,288 Added 11.51%
1,087,726 $46.2 Million
Q4 2018

Feb 13, 2019

SELL
$38.47 - $43.86 $182 Million - $207 Million
-4,719,286 Reduced 82.87%
975,438 $40.4 Million
Q3 2018

Nov 13, 2018

SELL
$34.47 - $41.81 $19.6 Million - $23.8 Million
-568,863 Reduced 9.08%
5,694,724 $251 Million
Q2 2018

Aug 10, 2018

BUY
$32.98 - $35.16 $108 Million - $116 Million
3,287,377 Added 110.46%
6,263,587 $227 Million
Q1 2018

May 09, 2018

SELL
$31.91 - $37.02 $16 Million - $18.6 Million
-501,229 Reduced 14.41%
2,976,210 $106 Million
Q4 2017

Feb 14, 2018

BUY
$33.26 - $35.29 $19.9 Million - $21.1 Million
598,977 Added 20.81%
3,477,439 $0
Q3 2017

Nov 13, 2017

BUY
$31.0 - $34.15 $89.2 Million - $98.3 Million
2,878,462
2,878,462 $103 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $154B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Federated Hermes, Inc. Portfolio

Follow Federated Hermes, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.